EUVIMEDEUVIMED entdecken
Open Access

Minimal Clinically Important Difference of the Scale for the Assessment and Rating of Ataxia

Gabriel Padilla, Yumeng Qi, Seonjoo Lee, Michael Spinner, Oliver Coultry, Scott Barbuto iD

Movement Disorders Clinical Practice · 2026-02 · 13 (2) · 509-514

DOI: 10.1002/mdc3.70343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 08.09.2025. Verfasst von Gabriel Padilla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lake Erie College of Osteopathic Medicine- Elmira, Elmira, New York, USA. Hauptthemen laut MEDLINE: Minimal Clinically Important Difference, Cerebellar Ataxia, Severity of Illness Index, Outcome Assessment, Health Care. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Scale for the Assessment and Rating of Ataxia (SARA) is the most used outcome measure in clinical trials for cerebellar ataxias. The minimal clinically important difference (MCID), a parameter used to assess meaningful change, is not clearly defined.

Objective

To help define MCID for SARA.

Methods

Sixty‐two individuals with cerebellar ataxias participated in a home‐exercise clinical trial. Participants had outcomes assessed [SARA, Timed Up and Go (TUG), Dynamic Gait Index (DGI), gait speed, Patient Global Impression of Change (PGIC)] at 0‐, 6‐, 9‐, and 12‐months. Three methods were used to determine the MCID for SARA: anchor‐based method, distribution‐based method, and distribution‐based mapping.

Results

The MCID for SARA using anchor‐based method was 1.75. The distribution‐based method and distribution‐based mapping identified a median MCID score of 1.23.

Conclusion

Synthesizing methods, we determined an MCID of 1.5 points. An accurate MCID is critical to ensure future treatments are clinically relevant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Minimal Clinically Important DifferenceCerebellar AtaxiaSeverity of Illness IndexOutcome Assessment, Health CareHumansMaleFemaleMiddle AgedAgedAdultGait

Stichwörter der Autor:innen

MCIDSARAataxiaoutcome measures

Autor:innen und Institutionen

  • Lake Erie College of Osteopathic Medicine- Elmira, Elmira, New York, USA.
  • Department of Psychiatry and Biostatistics, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.
  • Department of Mental Health Data Science, New York State Psychiatric Institute, New York, New York, USA.
  • Department of Physical Medicine and Rehabilitation, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.
  • Webster Schroeder High School, Webster, New York, USA.

ORCID-Profile: Scott Barbuto

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Padilla, G., Qi, Y., Lee, S., Spinner, M., Coultry, O., & Barbuto, S. (2026). Minimal Clinically Important Difference of the Scale for the Assessment and Rating of Ataxia. Movement Disorders Clinical Practice, 13(2), 509-514. https://doi.org/10.1002/mdc3.70343

Vancouver

Padilla G, Qi Y, Lee S, Spinner M, Coultry O, Barbuto S. Minimal Clinically Important Difference of the Scale for the Assessment and Rating of Ataxia. Movement Disorders Clinical Practice. 2026;13(2):509-514. doi:10.1002/mdc3.70343

BibTeX
@article{Padilla2026,
  author = {Padilla, Gabriel and Qi, Yumeng and Lee, Seonjoo and Spinner, Michael and Coultry, Oliver and Barbuto, Scott},
  title = {Minimal Clinically Important Difference of the Scale for the Assessment and Rating of Ataxia},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  volume = {13},
  number = {2},
  pages = {509--514},
  doi = {10.1002/mdc3.70343}
}
Kostenlos starten →